Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thorsten Stiewe

Showing results (161-170 of 167) with videos related to

Pageof 17
Sort By:
You have reached the last page of results.This site can display upto 167 results.
Cellular & Molecular Immunology|June 28, 2024
BAG6 restricts pancreatic cancer progression by suppressing the release of IL33-presenting extracellular vesicles and the activation of mast cellsBilal Alashkar Alhamwe, Viviane Ponath, Fahd Alhamdan, et al.
Journal of Virology|September 16, 2024
Distinct negative-sense RNA viruses induce a common set of transcripts encoding proteins forming an extensive networkNina Hofmann, Marek Bartkuhn, Stephan Becker, et al.
Cell Death and Differentiation|April 23, 2022
IRF4 deficiency vulnerates B-cell progeny for leukemogenesis via somatically acquired Jak3 mutations conferring IL-7 hypersensitivityDennis Das Gupta, Christoph Paul, Nadine Samel, et al.
Cell Reports. Medicine|November 20, 2024
Molecular adaptation to neoadjuvant immunotherapy in triple-negative breast cancerCarsten Denkert, Andreas Schneeweiss, Julia Rey, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 23, 2026
Clinical and Molecular Evaluation of HER2-Low and Ultralow Breast Cancer in the PENELOPE-B Clinical Trial CohortCarsten Denkert, Sivaramakrishna Rachakonda, Anika Pehl, et al.
Cancer Cell|February 11, 2025
Dynamics of molecular heterogeneity in high-risk luminal breast cancer-From intrinsic to adaptive subtypingCarsten Denkert, Sivaramakrishna Rachakonda, Thomas Karn, et al.
Leukemia|January 12, 2026
Randomized phase 3 trial of Ropeginterferon alfa-2b versus surveillance after tyrosine kinase inhibitor discontinuation in chronic myeloid leukemia (ENDURE/CML-IX)Andreas Burchert, Franck E Nicolini, Philipp le Coutre, et al.
Pageof 17

Showing results (161-170 of 167) with videos related to

Sort By:
Pageof 17
You have reached the last page of results.This site can display upto 167 results.
Cellular & Molecular Immunology|June 28, 2024
BAG6 restricts pancreatic cancer progression by suppressing the release of IL33-presenting extracellular vesicles and the activation of mast cellsBilal Alashkar Alhamwe, Viviane Ponath, Fahd Alhamdan, et al.
Journal of Virology|September 16, 2024
Distinct negative-sense RNA viruses induce a common set of transcripts encoding proteins forming an extensive networkNina Hofmann, Marek Bartkuhn, Stephan Becker, et al.
Cell Death and Differentiation|April 23, 2022
IRF4 deficiency vulnerates B-cell progeny for leukemogenesis via somatically acquired Jak3 mutations conferring IL-7 hypersensitivityDennis Das Gupta, Christoph Paul, Nadine Samel, et al.
Cell Reports. Medicine|November 20, 2024
Molecular adaptation to neoadjuvant immunotherapy in triple-negative breast cancerCarsten Denkert, Andreas Schneeweiss, Julia Rey, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 23, 2026
Clinical and Molecular Evaluation of HER2-Low and Ultralow Breast Cancer in the PENELOPE-B Clinical Trial CohortCarsten Denkert, Sivaramakrishna Rachakonda, Anika Pehl, et al.
Cancer Cell|February 11, 2025
Dynamics of molecular heterogeneity in high-risk luminal breast cancer-From intrinsic to adaptive subtypingCarsten Denkert, Sivaramakrishna Rachakonda, Thomas Karn, et al.
Leukemia|January 12, 2026
Randomized phase 3 trial of Ropeginterferon alfa-2b versus surveillance after tyrosine kinase inhibitor discontinuation in chronic myeloid leukemia (ENDURE/CML-IX)Andreas Burchert, Franck E Nicolini, Philipp le Coutre, et al.
Pageof 17